BrainStorm Cell Therapeutics Prices $4.0M Registered Direct Offering Of 11,111,111 Shares At $0.36/Share
Portfolio Pulse from Benzinga Newsdesk
BrainStorm Cell Therapeutics has announced a $4.0 million registered direct offering of 11,111,111 shares at a price of $0.36 per share.
June 27, 2024 | 1:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
BrainStorm Cell Therapeutics has announced a $4.0 million registered direct offering of 11,111,111 shares at a price of $0.36 per share. This move is likely to dilute existing shares and may put downward pressure on the stock price in the short term.
The direct offering will increase the number of shares outstanding, which typically dilutes the value of existing shares. The offering price of $0.36 per share is also below the current market price, which may lead to a short-term decline in the stock price as the market adjusts to the new supply of shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100